Skip to content

Beta Bionics, Inc.

United StatesFDA applicant, unverified FDA FEI 3019004087

Beta Bionics, Inc. is a medical device manufacturer, with 41 devices listed in FDA GUDID and FDA 510(k) (FDA Class II and I) and 3 FDA recalls as of 20 Nov 2026.

Devices
41
Registrations
FDA
FDA recalls
33 ongoing

Registry facts

Counted by deviCERTS from registry records, 20 Nov 2026

Registries
  • FDA GUDID 33
  • FDA 510(k) 8

A device listed in two registries counts in both.

Device classes
  • FDA Class II 40
  • FDA Class I 1
Identifiers
  • FDA FEI 3019004087
  • DUNS 835742136

At a glance

Counted by deviCERTS from registry records

Market reach

United States
FDA FEI, FDA recalls

What Beta Bionics, Inc. makes

Beta Bionics, Inc. makes ambulatory insulin infusion pumps and related components, including single-use infusion sets, reservoirs, cartridges, and connectors. The company also produces general-purpose syringes and hypodermic needles for single-use, as well as software for data display in ambulatory insulin infusion pump and interstitial glucose monitoring systems.

The devices are classified as Class II medical devices and are listed in the FDA 510(k) and FDA UDI registries.

AI-generated from registry data, 26 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue41

Newest first, rows 1-41 of 41

Search and filter all 41 devices
Skip device list

Rows 1-41 of 41

Company details

FDA FEI number
3019004087
DUNS number
835742136
Address
11 Hughes, Irvine, CA, 92618
Phone
855-745-3800

FDA recalls3

Recalls are matched to the firm by name. FDA recall data as of 1 Nov 2026.

FDA recall records list 3 recalls initiated by Beta Bionics, Inc., the earliest on 2025-08-13 and the most recent on 2026-03-12. By recorded status: 3 ongoing. The reasons filed fall into these groups: software or firmware. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.

Generated automatically from FDA recall records, as a summary of the records listed below. It describes what the records state and is not an assessment of this manufacturer.

Recalls initiated per year

  • 2017 0
  • 2018 0
  • 2019 0
  • 2020 0
  • 2021 0
  • 2022 0
  • 2023 0
  • 2024 0
  • 2025 2
  • 2026 1
  • 2026

    • 12 Mar 2026 Z-1996-2026 Class II Ongoing insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses provided, no correction doses/insulin reductions/suspensions for high/low glucose unless blood glucose entered for sensor life or replacement. Potential health risks to users include severe hyperglycemia with and without DKA and severe hypoglycemia. Distribution: US Nationwide distribution in the states of TX, PA, AL, MI, OH, FL, TN, GA. Submission number: K252770
  • 2025

    • 23 Sep 2025 Z-2513-2026 Class II Ongoing The reason for the recall is: it was found in version 3.3.6 of the iLet ACE Pump firmware and all previous releases that a screen unlock failure could occur when the user successfully slides the unlock slider on the Lock Screen, no screen transition occurs, and the user remains on the Lock Screen. Because the user cannot exit the Lock Screen, the user is unable to perform a cartridge change or meal announcement. If this occurs and therapy is in progress, therapy will continue normally until the insulin cartridge is depleted. The user will be unable to perform a cartridge change or a meal announcement and will be stuck on the screen until the battery fully drains. This can lead to hyperglycemia. Distribution: US: WI, HI, OH, ME, CO, NJ, NE, KY, SC, CA, TX, NH, NY, WA, PA, MD, FL, IA, GA, MI, VT, TN, IL, IN, KS, MA, LA, MS, NC,…
      Full distribution text US: WI, HI, OH, ME, CO, NJ, NE, KY, SC, CA, TX, NH, NY, WA, PA, MD, FL, IA, GA, MI, VT, TN, IL, IN, KS, MA, LA, MS, NC, CT, MN, VA, OK, AR, AZ, MO, MT, RI, DC, NM, OR, ID, NV, AK, ND, DE, WV, WY, SD, UT, AL
      Submission number: K252770
    • 13 Aug 2025 Z-1809-2026 Class II Ongoing it was found that in versions 1.3.7, 1.4.2, and 1.4.3, the Lock Screen and Limited Access Passcode Screen on the iLet graphical user interface (GUI) include certain icons displayed in the status bar that are active, thereby allowing the user to bypass those screens when those icons on the status bar are pressed, allowing unauthorized access while the device is in Limited Access Mode. A Health Risk associated with Limited access mode includes severe hypoglycemia due to unauthorized access to the iLet if someone were to make unauthorized meal announcements or stopped insulin delivery. Distribution: US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DE, FL, GA, ID, IL, IN, LA, MA, MD, ME,…
      Full distribution text US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DE, FL, GA, ID, IL, IN, LA, MA, MD, ME, MI, ME, MI, MN, MO, MT, NC, NE, NH, NJ, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WY AND WASHINGTON DC.
      Submission numbers: K231485, K232224

Frequently asked questions

How many devices does Beta Bionics, Inc. have in the registry?

The registry currently lists 41 devices for Beta Bionics, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Beta Bionics, Inc.'s devices?

Among its 41 most recently registered devices, Beta Bionics, Inc. has devices listed in FDA 510(k) (8 devices) and FDA GUDID (33 devices). A device can be listed in more than one registry, so these counts overlap.

What risk classes do Beta Bionics, Inc.'s devices fall under?

Among its 41 most recently registered devices, the classes recorded for Beta Bionics, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.

Are there FDA recall records for Beta Bionics, Inc.?

FDA recall records list 3 recalls initiated by Beta Bionics, Inc., the most recent initiated on 12 Mar 2026. 3 of them are recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.

What are the newest devices from Beta Bionics, Inc. in the registry?

The most recently registered devices listed for Beta Bionics, Inc. include iLet Insulin Infusion Kit Insulin Only, iLet Starter Kit Insulin Only, iLet Flex Insulin Infusion Set 5-Pack (23", 6mm) (BB1020) Insulin Only and Clinical Data and Visualization Application BOM000042.

Generated automatically from registry data and not verified by a human reviewer.